Genetronics Awarded Patent for Vascular Therapy

Genetronics Biomedical, a late-stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced that its subsidiary, Genetronics, has been granted another patent for a vascular application of its technology, namely U.S. Patent Number 6,865,416, entitled "Electrically Induced Vessel Vasodilation."

Money Plans (http://www.moneyplans.net/newsroom/news.php?action=fullnews&id=472)